IL44873A0 - New pyrazolo-s-triazine derivatives,their preparation and pharmaceutical compositions containing them - Google Patents

New pyrazolo-s-triazine derivatives,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL44873A0
IL44873A0 IL44873A IL4487374A IL44873A0 IL 44873 A0 IL44873 A0 IL 44873A0 IL 44873 A IL44873 A IL 44873A IL 4487374 A IL4487374 A IL 4487374A IL 44873 A0 IL44873 A0 IL 44873A0
Authority
IL
Israel
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
triazine derivatives
new pyrazolo
Prior art date
Application number
IL44873A
Other languages
English (en)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH725973A external-priority patent/CH581137A5/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL44873A0 publication Critical patent/IL44873A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C07D231/40—Acylated on said nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL44873A 1973-05-22 1974-05-21 New pyrazolo-s-triazine derivatives,their preparation and pharmaceutical compositions containing them IL44873A0 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CH725873 1973-05-22
CH725973A CH581137A5 (en) 1973-05-22 1973-05-22 Pyrazolo(1,5-a)-s-triazines - and their salts, with bronchospasmolytic activity
CH725773 1973-05-22
CH1694073 1973-12-04
CH442574 1974-03-29

Publications (1)

Publication Number Publication Date
IL44873A0 true IL44873A0 (en) 1974-07-31

Family

ID=27509197

Family Applications (1)

Application Number Title Priority Date Filing Date
IL44873A IL44873A0 (en) 1973-05-22 1974-05-21 New pyrazolo-s-triazine derivatives,their preparation and pharmaceutical compositions containing them

Country Status (8)

Country Link
JP (1) JPS5019769A (zh)
AU (1) AU6925974A (zh)
DD (1) DD113907A5 (zh)
DE (1) DE2424334A1 (zh)
FI (1) FI146174A (zh)
FR (1) FR2230366A1 (zh)
IL (1) IL44873A0 (zh)
NL (1) NL7406641A (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH635587A5 (fr) * 1978-01-09 1983-04-15 Aron Sa Derives amines de pyrazolo (1,5-a) s.triazine, therapeutiquement actifs et leurs procedes de preparation.
DE3942357A1 (de) * 1989-12-21 1991-06-27 Boehringer Mannheim Gmbh 3-aminopyrazolo-heterocyclen, deren verwendung zur bestimmung von wasserstoffperoxid, wasserstoffperoxid-bildenden systemen, peroxidase, peroxidatisch wirksamen substanzen oder von elektronenreichen aromatischen verbindungen, entsprechende bestimmungsverfahren und hierfuer geeignete mittel
FR2842809A1 (fr) * 2002-07-26 2004-01-30 Greenpharma Sas NOUVELLES PYRAZOLO[1,5-a]-1,3,5-TRIAZINES SUBSTITUEES ET LEURS ANALOGUES, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT, UTILISATION A TITRE DE MEDICAMENT ET PROCEDES POUR LEUR PREPARATION
FR2850653A1 (fr) * 2003-02-04 2004-08-06 Univ Pasteur Derives de pyrazolotriazine, procede de preparation et utilisations
EP1615930A2 (en) 2003-04-09 2006-01-18 Biogen Idec MA, Inc. Triazolotriazines and pyrazolotriazines useful as a2a adenosine receptor antagonists
US7834014B2 (en) 2003-04-09 2010-11-16 Biogen Idec Ma Inc. A2a adenosine receptor antagonists
US7674791B2 (en) 2003-04-09 2010-03-09 Biogen Idec Ma Inc. Triazolopyrazines and methods of making and using the same
PE20051128A1 (es) 2004-02-25 2006-01-16 Schering Corp Pirazolotriazinas como inhibidores de quinasa
JP5214799B2 (ja) 2008-04-07 2013-06-19 アイアールエム・リミテッド・ライアビリティ・カンパニー キナーゼ阻害剤としての化合物および組成物
WO2011089400A1 (en) 2010-01-22 2011-07-28 Centro Nacional De Investigaciones Oncológicas (Cnio) Inhibitors of pi3 kinase
WO2011141713A1 (en) 2010-05-13 2011-11-17 Centro Nacional De Investigaciones Oncologicas (Cnio) New bicyclic compounds as pi3-k and mtor inhibitors
GB201410817D0 (en) * 2014-06-17 2014-07-30 Ucb Biopharma Sprl And Katholieke Universiteit Leuven K U Leuven R & D Therapeutic agents
JP2018199623A (ja) * 2015-10-22 2018-12-20 大正製薬株式会社 含窒素縮合複素環化合物
WO2023094310A1 (en) * 2021-11-23 2023-06-01 Origenis Gmbh Pyrazolotriazine derivatives useful as cdk9 inhibitors

Also Published As

Publication number Publication date
FR2230366A1 (en) 1974-12-20
AU6925974A (en) 1975-11-27
DE2424334A1 (de) 1974-12-19
FI146174A (zh) 1974-11-23
DD113907A5 (zh) 1975-07-05
JPS5019769A (zh) 1975-03-01
FR2230366B1 (zh) 1977-11-10
NL7406641A (zh) 1974-11-26

Similar Documents

Publication Publication Date Title
IL44061A0 (en) New pyridine derivatives,their preparation and pharmaceutical compositions containing them
IL43872A0 (en) Novel imidazotriazines,their preparation and pharmaceutical compositions containing them
IL44202A (en) (3-amino-2-hydroxy-propoxy)-diazines and -pyridine derivatives,their manufacture and pharmaceutical compositions containing them
IL46259A0 (en) New phenoxypropylamine derivatives,their preparation and pharmaceutical compositions containing them
IL46050A0 (en) Azepinoquinoline derivatives,their preparation and pharmaceutical compositions containing them
IL45880A (en) 3-phenyl-1,2-benzisoxyzole derivatives,their preparation and pharmaceutical compositions containing them
IL45938A0 (en) Novel benzomorphane and morphinane derivatives,their preparation and pharmaceutical compositions containing them
IL45494A0 (en) Novel pyridine derivatives,their preparation and pharmaceutical compositions containing them
IL44873A0 (en) New pyrazolo-s-triazine derivatives,their preparation and pharmaceutical compositions containing them
IL46183A (en) 3-aminoalkylamino-1-phenoxy-2propanol derivatives,their preparation and pharmaceutical compositions comprising them
IL44427A0 (en) Dibenzothiepine derivatives,their manufacture and pharmaceutical compositions containing them
IL45609A0 (en) New isoquinoline derivatives,their preparation and pharmaceutical compositions containing them
IL46264A0 (en) New pyrazole derivatives,their preparation and pharmaceutical compositions containing them
IL44860A0 (en) Novel piperazine derivatives,their preparation and pharmaceutical compositions containing them
IL44222A0 (en) New diphenylpropylamines,their preparation and pharmaceutical compositions containing them
IL44095A0 (en) Novel diazepine derivatives,their preparation and pharmaceutical compositions containing them
IL44627A0 (en) New pyrazol-5-one derivatives,their preparation and pharmaceutical compositions containing them
IL44458A0 (en) New dibenzodiazepines,their preparation and pharmaceutical compositions containing them
IL44895A0 (en) New thiazoloisoquinolines,their preparation and pharmaceutical compositions containing them
IL45995A0 (en) New substituted thiazole-2-carboxamides,their preparation and pharmaceutical compositions containing them
IL44849A0 (en) New nitrocarbostyrils,their preparation and pharmaceutical compositions containing them
IL46116A0 (en) Novel alkenesulfonamides,their preparation and pharmaceutical compositions containing them
IL45950A (en) 2-glycylamido-4-pyridyl-thiazole derivatives their preparation and pharmaceutical compositions containing them
IL45970A0 (en) New thiazolylurea derivatives,their preparation and pharmaceutical compositions containing them
IL46292A0 (en) Derivatives of 1-phenoxy-3-aminopropan-2-ol,their preparation and pharmaceutical compositions containing them